a month ago
JAZZ
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 11%
#611 out of 5536 analysts
Average Return
+11.95%
Win Rate
58%62 out of 107
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Corcept Therapeutics IncCORT | +107.67% | $57.08 | $118.54 | 2026-05-13 - 2026-10-08 | Strong Buy |
Axsome Therapeutics IncAXSM | +106.13% | $103.26 | $212.85 | 2025-08-06 - 2026-08-05 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
a month ago
TEVA
2 months ago
ACAD
2 months ago
AMRX
3 months ago
MPLT
3 months ago
AMRX
3 months ago
CYTK
4 months ago
LEGN
5 months ago
JAZZ
5 months ago
CORT
5 months ago
ALKS
5 months ago
TEVA
6 months ago
RPRX
6 months ago
AXSM
9 months ago
AXSM
a year ago
JAZZ
a year ago
ABBV
a year ago
NBIX
a year ago
TEVA
2 years ago
TEVA
3 years ago
LEGN
3 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viatris IncVTRS | 3 | Strong Buy | $26.00 | +49.08% | Maintains | 4 days ago |
Neurocrine Biosciences IncNBIX | 13 | Strong Buy | $214.00 | +51.50% | Maintains | 10 days ago |
Jazz Pharmaceuticals PLCJAZZ | 9 | Strong Buy | $337.00 | +51.49% | Maintains | a month ago |
Teva Pharmaceutical Industries LtdTEVA | 12 | Strong Buy | $48.00 | +22.29% | Maintains | a month ago |
Assembly Biosciences IncASMB | 1 | Strong Buy | $52.00 | +127.87% | Initiates Coverage On | a month ago |
Acadia Pharmaceuticals IncACAD | 10 | Strong Buy | $49.00 | +150.26% | Maintains | 2 months ago |
Maplight Therapeutics IncMPLT | 3 | Hold | $13.00 | +42.08% | Downgrades | 2 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $25.00 | +27.23% | Maintains | 2 months ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Hold | $85.00 | +0.06% | Downgrades | 2 months ago |
Legend Biotech CorpLEGN | 6 | Hold | $28.00 | +49.65% | Downgrades | 3 months ago |
Exelixis IncEXEL | 6 | Hold | $52.00 | -11.89% | Maintains | 3 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $115.00 | +85.45% | Upgrades | 3 months ago |
Incyte CorpINCY | 4 | Hold | $113.00 | +0.22% | Maintains | 3 months ago |
Corcept Therapeutics IncCORT | 2 | Strong Buy | $72.00 | -39.26% | Upgrades | 5 months ago |
Alkermes PLCALKS | 6 | Strong Buy | $48.00 | +19.67% | Maintains | 5 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | +1.41% | Maintains | 6 months ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $259.00 | +52.28% | Maintains | 6 months ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +5.82% | Maintains | 7 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +32.32% | Maintains | 7 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +16.16% | Downgrades | 8 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +113.97% | Maintains | 9 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | -7.80% | Downgrades | 10 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | -19.24% | Maintains | a year ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | a year ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | N/A | Maintains | a year ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | 2 years ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.